ليست عنوان مقالات لاتين Hemorrhage activates catecholaminergic neurons sensitive to GABA in the nucleus of the solitary tract with ascending projections to the subfornical organ in rats Hepatitis C viral kinetics in plasma and peripheral blood mononuclear cells during pegylated interferon-α2a/ribavirin therapy

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Hemorrhage activates catecholaminergic neurons sensitive to GABA in the nucleus of the solitary tract with ascending projections to the subfornical organ in rats

2

Hemorrhage Activates Myocardial NFκB and Increases TNF-α in the Heart

3

Hemorrhage after pancreaticoduodenectomy: when is surgery still indicated?

4

Hemorrhage and the Use of Blood Products After Adult Cardiac Operations: Myths and Realities

5

Hemorrhage of the optic dik in normal-tenion glaucoma

6

Hemorrhage Treatment Report of Patients Suffering from Glanzmann’s Thrombasthenia Resulting Hospitalization from 2006 to 2011 at Mofid Children’s Hospital

7

Hemorrhages Seen on Brain Images After Mild Traumatic Brain Injury May Increase the Risk of Post-concussion Syndrome

8

Hemorrhagic and thrombotic disorders due to factor V deficiencies and abnormalities: an updated classification

9

Hemorrhagic ascites: an unusual manifestation of prostate carcinoma

10

Hemorrhagic Auricular Schwannoma: A case report

11

Hemorrhagic bowel syndrome in dairy cattle in Iran: a case report

12

Hemorrhagic brain metastases as a manifestation of metastatic malignant melanoma

13

Hemorrhagic cardiac tamponade in critically ill patients with acute renal failure

14

Hemorrhagic cerebral metastases from thyroid cancer on T2*-weighted gradient echo MRI

15

Hemorrhagic Complication from Glaucoma urgery in Patient on Anticoagulation Therapy or Antiplatelet Therapy Original Reearch Article

16

Hemorrhagic complication in an unupected macular choroidal melanoma

17

Hemorrhagic complications after nephron-sparing surgery: Angiographic diagnosis and management by transcatheter embolization: Heye S, Maleux G, Van Poppel H, Oyen R, Wilms G, Department of Radiology, University Hospitals Gasthuisberg, Belgium

18

Hemorrhagic Complications of Intravenous Heparin Use

19

Hemorrhagic Corpus Luteum is Associated with Ovarian Edema

20

Hemorrhagic Corpus Luteum With Generalized Abdominal Pain in Patients With Idiopathic Thrombocytopenic Purpura

21

Hemorrhagic Cystitis Following Cephalexin Overdose in a Child

22

HEMORRHAGIC DISEASE OF THE NEWBORN: CLINICAL PRESENTATION AND RESPONSE TO TREATMENT WITH VITAMIN K

23

Hemorrhagic enteritis virus induced changes in the lymphocyte subpopulations in turkeys and the effect of experimental immunodeficiency on viral pathogenesis

24

Hemorrhagic enteritis virus induced changes in the lymphocyte subpopulations in turkeys and the effect of experimental immunodeficiency on viral pathogenesis

25

Hemorrhagic Events During Therapy With Recombinant Tissue Plasminogen Activator, Heparin, and Aspirin for Unstable Angina (Thrombolysis In Myocardial Ischemia, Phase IIIB Trial)

26

Hemorrhagic Events in Patients Receiving Heparin or Enoxaparin in Combination With Oral Antithrombotics, NSAIDs, and Antiplatelet Medications: A Multi-Center Case-Series Study

27

Hemorrhagic Fever with Acute Renal Failure: A Report from Kosova

28

Hemorrhagic Fever With Renal Syndrome and Its History in Iran

29

Hemorrhagic Gastritis Associated with Renal Failure, Hemoglobinuria, and Isolation of Clostridium perfringens in a Horse

30

Hemorrhagic pericardial effusion leading to cardiac tamponade, as presenting feature of COVID-19 in a young man: a case report

31

Hemorrhagic Posterior Reversible Encephalopathy Syndrome: A Rare Neurological Complication of COVID-19 Infection

32

Hemorrhagic shock from a ruptured ectopic pregnancy in a patient with a negative urine pregnancy test result

33

Hemorrhagic type Moyamoya disease

34

Hemostasis and exercise

35

Hemostasis as an optimal system

36

Hemostasis by means of a cautery knife equipped with an air spray for burns over a large area

37

Hemostasis in Hypothyroidism and Autoimmune Thyroid Disorders

38

Hemostasis in newborns of smoking and nonsmoking mothers, ,

39

Hemostasis in Off-Pump Compared to On-Pump Coronary Artery Bypass Grafting: A Prospective, Randomized Study

40

Hemostasis in Oral Surgery

41

Hemostasis in Overt and Subclinical Hyperthyroidism

42

Hemostasis in the uteroplacental and peripheral circulations in normotensive and pre-eclamptic pregnancies, , , ,

43

Hemostasis in uncontrolled esophageal variceal bleeding by self−expanding metal stents: a systematic review

44

Hemostasis Management in Pediatric Mechanical Circulatory Support

45

Hemostasis of the femoral vasculature: Shouldn’t we have an answer by now?, ,

46

Hemostasis of Tiger Prawn Penaeus monodon Affected by Vibrio harveyi, Extracellular Products, and a Toxic Cysteine Protease

47

Hemostasis success rates and local complications with collagen after femoral access for cardiac catheterization: Analysis of 6007 published patients, ,

48

Hemostatic abnormalities in patients with congestive heart failure: diagnostic significance and clinical challenge

49

Hemostatic Agents

50

Hemostatic agents in orthodontics: A review

51

Hemostatic agents versus sutured bolster during laparoscopic partial nephrectomy

52

Hemostatic capability of rapidly curable glues from gelatin, poly(L-glutamic acid), and carbodiimide

53

Hemostatic effect of activated recombinant factor VII (rFVIIa) in liver disease: studies in an in vitro model

54

Hemostatic effects of aprotinin, tranexamic acid and ε-aminocaproic acid in primary cardiac surgery

55

Hemostatic Efficacy of Ankaferd Blood Stopper in a Swine Bleeding Model

56

Hemostatic efficacy of dipyridamole, tranexamic acid, and aprotinin in coronary bypass grafting

57

Hemostatic factors, atherogenesis and atherosclerosis

58

Hemostatic Molecular Markers Before the Onset of Disseminated Intravascular Coagulation

59

Hemostatic parameters in pulmonary tuberculosis patients after intensive phase treatment

60

Hemostatic responses to maximal exercise in oral contraceptive users

61

Hemostatic risk factors of coronary artery disease in the Chinese

62

Hemostatic Role of TachoSil Surgical Patch in Cardiac Surgery

63

Hemostatic state and atrial fibrillation (The Framingham Offspring Study)

64

Hemostatic Tampon to Reduce Bleeding following Tooth Extraction

65

Hemosuccus pancreaticus as a rare cause of gastrointestinal bleeding: a report of two cases.

66

Hemosuccus Pancreaticus in a Patient with Celiac Trunk Aneurysm

67

Hemothorax as the first manifestation of idiopathic pulmonary arteriovenous malformation

68

Hemothorax in type I neurofibromatosis

69

Hemotoxicity of carbon nanotubes

70

Hemotropic Mycoplasmas in Stray Cats in Kerman, Iran

71

Hemoxygenase-1 in Cardiovascular Disease

72

Hemozoin Enhances Maturation of Murine Bone Marrow Derived Macrophages and Myeloid Dendritic Cells

73

Hemp diseases and pests. Management and biological control. An advanced treatise J.M. McPartland, R.C. Clarke and D.P. Watson; CABI Publishing Wallingford, Oxon, price £49.95 (US$90), ISBN 0-85199-454-7

74

Hemp fibre reinforced cashew nut shell liquid composites

75

Hemp fibre reinforced cashew nut shell liquid composites

76

Hemp fibre reinforced composites using chelator and enzyme treatments

77

Hemp Fibres as Novel Green Support Material for Immobilization of Acidithiobacillus ferrooxidans

78

Hemp seed cake in organic broiler diets

79

Hemp seed/evening primrose oil affects expression of STAT3, IL-17, and FOXP3+ in experimental autoimmune encephalomyelitis

80

Hemp: A more sustainable annual energy crop for climate and energy policy

81

HEMP-derived activated carbon fibers by chemical activation with phosphoric acid

82

Hempel S. The Medical Detective: John Snow and the Mystery of Cholera [title in USA ‘The Strange case of the Broad Street Pump] Granta Books, 2006, pp304 ISBN 1-862-07842-4 Hardback £18.99

83

Hempelʹs Raven paradox: a positive approach to cluster analysis

84

Hempseed protein derived antioxidative peptides: Purification, identification and protection from hydrogen peroxide-induced apoptosis in PC12 cells

85

Hemşehrilik and Favouritism in the Context of Political and Civil Society Organizations

86

HEMŞİRELERİN İŞ GÜCÜ VERİMLİLİĞİNİ ETKİLEYEN ÖRGÜTSEL FAKTÖRLER KONUSUNDAKİ TUTUMLARININ BELİRLENMESİ

87

HEMŞİRELERİN ÖRGÜTSEL VATANDAŞLIK DÜZEYLERİNİN BELİRLENMESİ

88

HEMT modelling using semi-physical expressions for the equilibrium space-charge parameters of the modulation-doped heterojunction

89

Hen egg white as a feeder protein for lipase immobilization

90

Hen egg white fractionation by ion-exchange chromatography

91

Hen Egg Yolk Prevents Bacterial Adherence: A Novel Function for a Familiar Food

92

Hen’s egg white hypersensitivity among a group of Egyptian atopic children

93

Hen’s eggshell strength under impact loading Original Research Article

94

HEN-1, a Secretory Protein with an LDL Receptor Motif, Regulates Sensory Integration and Learning in Caenorhabditis elegans

95

Henbit (Lamium amplexicaule L.) control and forage legume tolerance to selected postemergence herbicides

96

Hencky’s logarithmic strain and dual stress–strain and strain–stress relations in isotropic finite hyperelasticity

97

Hendra (Equine Morbillivirus)

98

Hendra virus influences meningoencephalitis-based mortality: A comprehensive review

99

Hendra Virus: A Highly Lethal Zoonotic Agent

100

Hendra-like virus responsible for epidemic in Malaysia

101

He-Ne Laser Irradiation Encourages reparative processes After cartilage loss in New Zealand rabbits

102

HeNe+: resolution of an apparent disagreement between experiment and theory

103

Hengill geothermal volcanic complex (Iceland) characterized by integrated geophysical observations

104

Henipavirus susceptibility to environmental variables

105

Henk F. Moed, Wolfgang Glänzel and Ulrich Schmoch, Editors, Handbook of Quantitative Science and Technology Research: The Use of Publication and Patent Statistics in Studies of S&T Systems, Kluwer Academic Publishers (2004) ISBN 1 4020 2702 8 Hardback (al

106

Henk Postma, 1921–2005

107

Henkelʹs strategy for Asia Pacific

108

Henna, An Antimicrobial Herbal Medicine With Less Negative Effect on Spermatogonial Stem Cell Culture

109

Henney nomination moves forward

110

Henneyʹs FDA nomination on “hold”

111

Hennie Van Greuning, International financial reporting standards — A practical guide (2nd edition), The World Bank, Washington (USA) (2005) ISBN 0-8213-5910-X x+297 p, US$30.00.

112

Henoch Schonlein Purpura in children: clinical analysis of 120 cases

113

Henoch–Sch ̈onlein Purpura Associated with Lung Cancer: When Paraneoplastic Manifestations Impede Oncological Management

114

Henoch-Schoenlein Purpura Following Severe Acute Respiratory Syndrome Coronavirus-2 Infection: A Case Report

115

Henoch-Schönlein purpura

116

Henoch-Schonlein Purpura Associated with Methicillin-Resistant Staphylococcus aureus Infection

117

Henoch-Schonlein Purpura in A Child Complicated by Fatal Pulmonary Hemorrhage

118

Henoch-Schonlein Purpura in an Elderly Women Presenting with Severe GI Bleeding: A case report

119

Henoch-Schonlein purpura in children

120

Henoch-Schonlein Purpura in Northeast India: Peculiarities in Presentation

121

Henoch-Schönlein purpura with intracerebral hemorrhage

122

Henoch-Schönlein syndrome induced by carbidopa/levodopa

123

Hénon–Heiles potential as a bridge between nontopological solitons of different types

124

HENOSEPILACHNA SEPTIMA DIEKE (COCCINELLIDAE; COLEOPTERA); A NEW RECORD FOR PAKISTAN ALONG WITH NOTES ON ITS TAXONOMY, HOST PLANTS AND DISTRIBUTION

125

HENOSEPILACHNA VIGINTIOCTOPUNCTATA (FAB.) (EPILACHNINAE; COCCINELLIDAE); ITS TAXONOMY, DISTRIBUTION AND HOST PLANTS IN PAKISTAN.

126

Henri Theil, 1924–2000

127

Henri Wallonʹs Theory of Early Child Development: The Role of Emotions

128

Henrian ideality of iron in liquid uranium solvent at high temperatures

129

Henriciʹs transformation and its application to the computation of derivatives of eigensystems

130

Henricus Mattheus Princen

131

Henrik Kacser (1918–1995): an Annotated Bibliography

132

133

Henriksen and Isbell on f-rings

134

Henriksenʼs contributions to residue class rings of analytic and entire functions

135

Henry Adams and the question of posthistoire

136

Henry Arthur Solomon, MD: a conversation with the editor

137

Henry Bowditch and “The Young Stethoscopist”

138

Henry condensations with 4,6-O-benzylidenylated and non-protected d-glucose and l-fucose via DBU-catalysis

139

Henry Darger: Art and Selected Writings: Michael Bonesteel;Rizzoli International Publications, Inc., New York, 2000, 256 pages, 125 color illustrations; hardbound, $85

140

Henry Hobson Richardson and the small public library in America: A study in topology : Breisch, Kenneth A. Cambridge, MA: MIT Press, 1997. 343 pp. $50.00. ISBN: 0-262-2416-0

141

Henry Hugh Higgins and Frederick Price Marrat: the reluctant palaeobotanists and the Ravenhead collection

142

Henry James and the New Woman: A Feminist Reading of The Bostonians

143

Henry kempe memorial lecture—10th International congress on child abuse and neglect : Child abuse and neglect from an indigenous Australianʹs perspective

144

Henry reaction of fluorinated nitro compounds

145

Henry S. Kaplan Distinguished Scientist Award 2003

146

Henry Swan II, MD

147

Henry Swan II, MD

148

Henry Vartan Kehiaian (1929–2009)

149

Henry W. Lane, Martha L. Maznevski, Mark E. Mendenhall and Jeanne McNett, Editors, The Blackwell Handbook of Global Management: A Guide to Managing Complexity, Blackwell Publishers, Malden, MA (2004).

150

Henry, C.J.K. (Ed.) Novel food ingredients for weight control, Woodhead Publishing Ltd., Cambridge, UK, 2007 (xiv + 358 pp., £135.00, ISBN 1-84569-030-4).

151

Henry, C.J.K. (Ed.) Novel food ingredients for weight control, Woodhead Publishing Ltd., Cambridge, UK, 2007 (xiv + 358 pp., £135.00, ISBN 1-84569-030-4).

152

Henry’s constants of butane, isobutane, 1-butene and isobutene in methanol at 255–320 K

153

Henry’s constants of carbon dioxide in methanol at 250–500 K

154

Henry’s constants of methanol in aqueous systems containing salts

155

Henry’s law constant measurements for formaldehyde and benzaldehyde as a function of temperature and water composition

156

Henry’s law constant, octanol–air partition coefficient and supercooled liquid vapor pressure of carbazole as a function of temperature: Application to gas/particle partitioning in the atmosphere

157

Henry’s law constants and isosteric heats of adsorption at zero loading for multi-wall carbon surfaces with different geometries Original Research Article

158

Henry’s law constants and mass transfer coefficients for methyl bromide and 1,3-dichloropropene applied to Florida sandy field soil

159

Henry’s law constants derived from equilibrium static cell measurements for dilute organic–water mixtures

160

Henry’s law constants for hexachlorobenzene, p,p′-DDE and components of technical chlordane and estimates of gas exchange for Lake Ontario

161

Henry’s law constants of methane, nitrogen, oxygen and carbon dioxide in ethanol from 273 to 498 K: Prediction from molecular simulation

162

Henry’s law constants of phenol and mononitrophenols in water and aqueous sulfuric acid Original Research Article

163

Henry–Nef reaction: a practical and versatile chiral pool route to 2-substituted pyrrolidine and piperidine alkaloids

164

Henryʹs constants of gases and volatile organic compounds in aqueous solutions

165

Henryʹs constants of n-alkanols (methanol through n-hexanol) in water at temperatures between 40°C and 90°C

166

Henryʹs constants of propane, propene, trans-2-butene and 1,3-butadiene in methanol at 255–320 K

167

Henryʹs Law and the solubilities of reactant gases in the modelling of PEM fuel cells

168

Henryʹs Law coefficients of chloropicrin and methyl isothiocyanate

169

Henryʹs law constant and related coefficients for aqueous hydrocarbons, CO2 and H2S over a wide range of temperature and pressure

170

Henryʹs law constant measurements for phenol, o-, m-, and p-cresol as a function of temperature

171

Henryʹs law constants and hydrolysis rate constants of 2,2,2-trifluoroethyl acetate and methyl trifluoroacetate

172

Henryʹs law constants for a diverse set of organic chemicals: Experimental determination and comparison of estimation methods

173

Henryʹs law constants for C2–C3 fluorinated alcohols and their wet deposition in the atmosphere

174

Henryʹs law constants for α-, β-, and γ-hexachlorocyclohexanes (HCHs) as a function of temperature and revised estimates of gas exchange in Arctic regions

175

Henryʹs law constants measurements of alachlor and dichlorvos between 283 and 298 K

176

Henryʹs law constants measurements of the nonylphenol isomer 4(3′,5′-dimethyl-3′-heptyl)-phenol, tertiary octylphenol and γ-hexachlorocyclohexane between 278 and 298 K

177

Henryʹs law constants of 1-butene, 2-methylpropene, trans-2-butene, and 1,3-butadiene in methanol at 374–490 K

178

Henryʹs law constants of 2,2,2-trifluoroethyl formate, ethyl trifluoroacetate, and non-fluorinated analogous esters

179

Henryʹs law constants of halogenated organic acids

180

Henryʹs law constants of propane, propene, butane, and 2-methylpropane in methanol at 374–490 K

181

Hens are motivated to dustbathe in peat irrespective of being reared with or without a suitable dustbathing substrate

182

Hens’ welfare to egg quality: a European perspective

183

Hensel′s Lemma and the Divisibility by Primes of Stirling-like Numbers Original Research Article

184

Henselian residually p-adically closed fields

185

Henselian Valued Stable Fields

186

Hensleyʼs problem for complex and non-Archimedean meromorphic functions

187

Henstock type integral in harmonic analysis on zero-dimensional groups

188

Henstock–Kurzweil delta and nabla integrals ✩

189

Henstock–Kurzweil–Pettis integrability of compact valued multifunctions with values in an arbitrary Banach space

190

Henstockʹs multiple wiener integral and henstockʹs version of hu-meyer theorem

191

heoretical studies on shuttle checking: Part II-Shuttle checking by swell P K Hari K N Gupta B K Behera S G Joshi

192

heoretical studies on shuttle checking: Part II-Shuttle checking by swell P K Hari K N Gupta B K Behera S G Joshi

193

heory of Markov systems with fuzzy states

194

Hep atop rotective Potentials of Ghrelin and/or N-Acetyl Cysteine in Thioacetamide Induced Chronic Liver Injury in Rats

195

Hep atop rotective Role for Querectin in Diabetic Rats: Hypolipidemic and Antioxidant Effects

196

HEP computing in Korea Original Research Article

197

HEp-2 cell classification using rotation invariant co-occurrence among local binary patterns

198

HEp-2 cell image classification with multiple linear descriptors

199

HEp-2 cell pattern classification with discriminative dictionary learning

200

HEp-2 cells classification via sparse representation of textural features fused into dissimilarity space

201

HEp-2 fluorescence pattern classification

202

HEp-2 image classification using intensity order pooling based features and bag of words

203

HEPACAM1 and 2 are differentially regulated in canine mammary adenomas and carcinomas and its lymph node metastases

204

Hepadnaviral hepatocarcinogenesis: in situ visualization of viral antigens, cytoplasmic compartmentation, enzymic patterns, and cellular proliferation in preneoplastic hepatocellular lineages in woodchucks

205

Heparan sulfate abnormalities in exostosis growth plates

206

Heparan sulfate is the main sulfated glycosaminoglycan species in internal organs of the male cockroach, Periplaneta americana

207

Heparan sulfate isomers in cerebral arteries of Japanese women with aging and with atherosclerosis—heparitinase and high-performance liquid chromatography determinations

208

Heparan sulfate proteoglycans. Essential co-factors in receptor-mediated processes with relevance to the biology of the vascular wall Original Research Article

209

Heparan Sulfate: A Complex Polymer Charged with Biological Activity

210

Heparan sulphate proteoglycans in Alzheimerʹs disease and amyloid-related disorders

211

Heparanase expression and activity influences chondrogenic and osteogenic processes during endochondral bone formation

212

Heparanase expression in human leukemias is restricted to acute myeloid leukemias

213

Heparanase Gene Hypomethylation as a Potential Biomarker for Precision Screening of Bladder Cancer

214

Heparanase promotes bone destruction and invasiveness in prostate cancer

215

Heparanase Regulates Thrombosis in Vascular Injury and Stent-Induced Flow Disturbance

216

Heparanase, heparan sulfate and perlecan distribution along with the vascular penetration during stellate reticulum retraction in the mouse enamel organ

217

Heparan-like molecules induce the repair of skull defects

218

Heparin accelerates liver regeneration following portal branch ligation in normal and cirrhotic rats with increased plasma hepatocyte growth factor levels

219

Heparin Activates PKR by Inducing Dimerization

220

Heparin affects matrix metalloproteinases and tissue inhibitors of metalloproteinases circulating in peripheral blood

221

Heparin after percutaneous intervention (HAPI): prospective multicenter randomized trial of three heparin regimens after successful coronary intervention

222

Heparin and aspirin attenuate placental apoptosis in vitro: Implications for early pregnancy failure

223

Heparin and aspirin in stroke

224

Heparin and aspirin in stroke

225

Heparin and aspirin in unstable angina: Insufficient sample size may lead to erroneous conclusions

226

Heparin and inflammatory bowel disease

227

Heparin and its derivatives in the treatment of arterial thrombosis: a review

228

Heparin and Low Molecular Weight Heparin Decrease Nitric Oxide Production by Human Polymorphonuclear Cells

229

heparin and platelet function

230

Heparin and the nonanticoagulant N-acetyl heparin attenuate capillary no-reflow after normothermic ischemia of the lung

231

Heparin antiproliferative activity on bovine pulmonary artery smooth muscle cells requires both N-acetylation and N-sulfonation Original Research Article

232

Heparin as adjunctive therapy to coronary thrombolysis in acute myocardial infarction

233

Heparin as an adjuvant to thrombolytic therapy in acute myocardial infarction

234

Heparin attenuates cytotoxic and inflammatory activity of Alzheimer amyloid-β in vitro

235

Heparin binding activity of orf virus F1L protein

236

Heparin Binding and Augmentation of C1 Inhibitor Activity

237

Heparin Binds to the Laminin α4 Chain LG4 Domain at a Site Different from that Found for Other Laminins

238

Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypass

239

Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass

240

Heparin Causes the Accumulation of Heparan Sulfate in Cultures of Arterial Smooth Muscle Cells

241

Heparin coated Palmaz-Schatz™ stents are highly thrombo-resistant: baboon A-V shunt study

242

Heparin coated poly(alkylcyanoacrylate) nanoparticles coupled to hemoglobin: a new oxygen carrier

243

Heparin coating dramatically reduces platelet deposition on incompletely deployed Palmaz-Schatz™ in the baboon A-V shunt

244

Heparin coating of bypass systems

245

Heparin coating of poly(ethylene terephthalate) decreases hydrophobicity, monocyte/leukocyte interaction and tissue interaction

246

Heparin coating of the stent graft — effects on platelets, coagulation and complement activation

247

Heparin Coating With Aprotinin Reduces Blood Activation During Coronary Artery Operations

248

Heparin cofactor II (RbHCII) from rock bream (Oplegnathus fasciatus): Molecular characterization, cloning and expression analysis

249

Heparin column analysis of serum type 5 tartrate-resistant acid phosphatase isoforms

250

Heparin conjugated silica nanoparticle synthesis

251

Heparin coupling in inhibition of calcification of vascular bioprostheses

252

Heparin crosslinked chitosan microspheres for the delivery of neural stem cells and growth factors for central nervous system repair

253

Heparin delivery at the site of angioplasty with a nevel drug delivery sleeve

254

Heparin dosing and outcome in acute coronary syndromes: The GUSTO-IIb experience

255

Heparin effect on platelets and fibrinolysis

256

Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity

257

Heparin for acute ischaemic stroke: a never-ending story?

258

Heparin functionalized PEG gels that modulate protein adsorption for hMSC adhesion and differentiation

259

Heparin in acute coronary syndromes

260

Heparin in calcification prevention of porcine pericardial bioprostheses

261

Heparin in sepsis treatment

262

Heparin in sepsis treatment – Authorsʹ reply

263

Heparin in the treatment of burns: a review

264

Heparin in unstable angina

265

Heparin incorporating liposomes as a delivery system of heparin from PET-covered metallic stents: Effect on haemocompatibility

266

Heparin- induced thrombocytopenia (HIT): a case report of CABG patient

267

Heparin Infusion Prior to Stenting (HIPS) trial: Final results of a prospective, randomized, controlled trial evaluating the effects of local vascular delivery on intimal hyperplasia

268

Heparin Initiation Before and After Femoral Arterial Access in Primary Percutaneous Coronary Intervention: Side Effects and Angiographic Success Rates

269

Heparin intercalation into reconstituted collagen I fibrils: Impact on growth kinetics and morphology

270

Heparin interference in whole blood sodium measurements in a pediatric setting

271

Heparin Is More Effective Than Inogatran, a Low-Molecular Weight Thrombin Inhibitor in Suppressing Ischemia and Recurrent Angina in Unstable Coronary Disease

272

Heparin oligosaccharide sequence and size essential for inhibition of pulmonary artery smooth muscle cell proliferation

273

Heparin potentiates collateral growth but not growth of intramyocardial endarteries in dogs with repeated coronary occlusion

274

Heparin preserves nitric oxide activity in coronary endothelium during ischemia-reperfusion injury

275

Heparin prophylaxis in bedridden patients

276

Heparin receptors in two murine mammary adenocarcinomas with different metastatic ability: relationship with growth inhibition

277

Heparin Resistance During and Post-Intravenous Nitroglycerin Infusion

278

Heparin Reverses Anaphylactoid Shock in a Porcine Model

279

Heparin reverses Rhodamine 123 extrusion by multidrug resistant cells

280

Heparin study sparks controversy among cardiologists

281

Heparin therapy for deep vein thrombosis: from hospital to home

282

Heparin therapy in electrical burns: First study and pictures

283

Heparin Thromboprophylaxis for Medical Inpatients

284

Heparin use complicates cardiological procedures

285

Heparin versus aspirin in ischaemic stroke

286

Heparin versus aspirin in ischaemic stroke

287

Heparin versus aspirin in ischaemic stroke

288

Heparin vs aspirin in acute ischaemic stroke

289

Heparin, cell adhesion, and pathogenesis of inflammatory bow el disease

290

Heparin, Enoxaparin, and Mechanical Prophylaxis Utilization Evaluation in DVT Prophylaxis in a Major Teaching Hospital in West of Iran

291

Heparinase-II-Catalyzed Degradation of N-Propionylated Heparin

292

Heparin-binding activity of feline herpesvirus type 1 glycoproteins

293

Heparin-binding EGF-like growth factor induces expression of lectin-like oxidized LDL receptor-1 in vascular smooth muscle cells

294

Heparin-bonded circuits decrease myocardial ischemic damage

295

Heparin-Bonded Circuits Decrease Myocardial Ischemic Damage: An Experimental Study

296

Heparin-bonded circuits with a reduced anticoagulation protocol in primary CABG: a prospective, randomized study

297

Heparin-Bonded Covered Stents Versus Bare-Metal Stents for Complex Femoropopliteal Artery Lesions: The Randomized VIASTAR Trial (Viabahn Endoprosthesis With PROPATEN Bioactive Surface [VIA] Versus Bare Nitinol Stent in the Treatment of Long Lesions in Sup

298

Heparin-bonded surfaces in extracorporeal membrane oxygenation for cardiac support

299

Heparin-coated bypass circuits in cardiopulmonary bypass: Improved biocompatibility or not

300

Heparin-coated bypass circuits: effects on inflammatory response in pediatric cardiac operations

301

Heparin-coated circuits and aprotinin prime for coronary artery bypass grafting

302

Heparin-coated circuits and reduced systemic anticoagulation applied to 2500 consecutive first-time coronary artery bypass grafting procedures

303

Heparin-coated circuits for high-risk patients: a multicenter, prospective, randomized trial

304

Heparin-coated circuits reduce myocardial injury in heart or heart-lung transplantation: a prospective, randomized study

305

Heparin-Coated Equipment Reduces the Risk of Oxygenator Failure

306

Heparin-coated Wiktor stents in human coronary arteries (MENTOR Trial)

307

Heparin-conjugated scaffolds with pore structure of inverted colloidal crystals for cartilage regeneration

308

Heparin-decorated, hyaluronic acid-based hydrogel particles for the controlled release of bone morphogenetic protein 2

309

Heparin-doped affinity electromembranes for thrombin purification

310

Heparin-folate-retinoic acid bioconjugates for targeted delivery of hydrophobic photosensitizers

311

Heparin-free hemodialysis in the treatment of hypernatremia in severely burned patients

312

Heparin-functionalized chitosan scaffolds for bone tissue engineering Original Research Article

313

Heparin-functionalized polymeric biomaterials in tissue engineering and drug delivery applications

314

Heparin-immobilized polymers as non-inflammatory and non-thrombogenic coating materials for arsenic trioxide eluting stents

315

Heparin-independent mitogenicity in an endothelial and smooth muscle cell chimeric growth factor (S130K-HBGAM)

316

Heparin-induced aldosterone suppression and hyperkalemia

317

Heparin-induced antibodies as a risk factor for thromboembolism and haemorrhage in patients undergoing chronic haemodialysis

318

Heparin-Induced Cancer Cell Death Review Article

319

Heparin-induced CVA

320

Heparin-induced hyperkalemia after cardiac surgery

321

Heparin-induced platelet dysfunction and cardiopulmonary bypass

322

Heparin-Induced Thrombocytopeni

323

Heparin-induced thrombocytopenia

324

Heparin-induced thrombocytopenia and cardiac surgery

325

Heparin-induced thrombocytopenia and cardiac surgery

326

Heparin-induced thrombocytopenia and cardiopulmonary bypass: perioperative argatroban use

327

Heparin-induced thrombocytopenia and cardiovascular diseases

328

Heparin-induced thrombocytopenia and heart operation: Management with tedelparin

329

Heparin-Induced Thrombocytopenia Associated With Bilateral Adrenal Hemorrhage After Coronary Artery Bypass Surgery

330

Heparin-induced thrombocytopenia in coronary bypass surgery

331

Heparin-Induced Thrombocytopenia in Left Ventricular Assist Device Bridge-to-Transplant Patients

332

Heparin-induced thrombocytopenia in the emergency department

333

Heparin-induced thrombocytopenia is rare in pregnancy

334

Heparin-induced thrombocytopenia with thrombotic sequelae: a review

335

Heparin-induced thrombocytopenia: an overview

336

Heparin-induced thrombocytopenia: bovine versus porcine heparin in cardiopulmonary bypass surgery

337

Heparin-induced thrombocytopenia: clinical manifestations and management strategies

338

Heparinization of gas plasma-modified polystyrene surfaces and the interactions of these surfaces with proteins studied with surface plasmon resonance

339

Heparinized and Saline Solutions in the Maintenance of Arterial and Central Venous Catheters After Cardiac Surgery

340

Heparinized bovine pericardium as a novel cardiovascular bioprosthesis

341

Heparinized cardiopulmonary bypass and full heparin dose marginally improve clinical performance

342

Heparin-like anticoagulant activity of sulphonated poly(ethylene oxide) and sulphonated poly(ethylene oxide)-grafted polyurethane

343

Heparin-like compounds prepared by chemical modification of capsular polysaccharide from E. coli K5

344

Heparin-like functionalized polymer surfaces: discrimination between catalytic and adsorption processes during the course of thrombin inhibition

345

Heparinoid Anticoagulation and Topical Fibrin Sealant in Heparin-Induced Thrombocytopenia

346

Heparinoid-active two sulfated polysaccharides isolated from marine green algae Monostroma nitidum

347

Heparinoid-active two sulfated polysaccharides isolated from marine green algae Monostroma nitidum

348

Heparin–platelet factor 4 antibodies in patients presenting to the ED with thrombosis

349

Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF

350

Heparin-related thrombosis despite normal platelet counts in vascular surgery

351

Heparin-released extracellular superoxide dismutase is reduced in patients with coronary artery atherosclerosis

352

Heparins in management of acute coronary syndromes without ST-segment elevation

353

Heparin-stimulated expression of extracellular-superoxide dismutase in human fibroblasts

354

Hepatectomy for liver metastases from breast cancer

355

Hepatectomy using traditional Péan clamp–crushing technique under intermittent Pringle maneuver

356

Hepatic “split lesion” in a fatal electrocution case

357

Hepatic “Stem” Cells: Coming Full Circle

358

Hepatic 18F-FDG Uptake Measurements on PET/MR: Impact of Volume of Interest Location on Repeatability

359

Hepatic 5′-AMP-Activated Protein Kinase: Zonal Distribution and Relationship to Acetyl-CoA Carboxylase Activity in Varying Nutritional States

360

Hepatic 7-ethoxyresorufin O-deethylase Activity in eel (Anguilla Anguilla) from The Thames Estuary and Comparisons with other United Kingdom Estuaries

361

Hepatic abscess caused by Brucella US, CT and MRI findings: Case report and review of the literature

362

Hepatic activities of CYP1A and thiamine-dependent enzymes in Baltic salmon (Salmo salar) alevins suffering from the thiamine deficiency M74

363

Hepatic Acyl CoA Oxidase1 Inhibition Modifies Brain Lipids and Electrical Properties of Dentate Gyrus

364

Hepatic adenoma and focal nodular hyperplasia: mr findings with superparamagnetic iron oxide– enhanced mri

365

Hepatic adenomatosis: MRI demonstration with the use of superparamagnetic iron oxide

366

Hepatic allograft abscess with hepatic arterial thrombosis

367

Hepatic Alterations in the Amphibian Sclerophrys regularis as Biomarkers for Habitat Destruction

368

Hepatic alterations in the fish Rhamdia quelen contaminated with Folidol 600®

369

Hepatic Alveolar Echinococcosis

370

Hepatic alveolar echinococcosis: MRI findings

371

Hepatic Alveolar Hydatid Cyst: A Brief Review of Published Cases from Iran in the Last 20 Years

372

Hepatic amino acid and protein metabolism in non-anorectic, moderately cachectic tumor-bearing rats

373

Hepatic amino nitrogen conversion and organ N-contents in hypothyroidism, with thyroxine replacement, and in hypethyroid rats

374

Hepatic amino- to urea-N clearance and forearm amino-N exchange during hypoglycemic and euglycemic hyperinsulinemia in normal man

375

Hepatic anaplerotic outflow fluxes are redirected from gluconeogenesis to lactate synthesis in patients with Type 1a glycogen storage disease

376

Hepatic and biliary biomarkers in rainbow trout injected with sediment extracts from the River Po (Italy)

377

Hepatic and extrahepatic dehydrogenation/isomerization of 5-cholestene-3β,7α-diol: localization of 3β-hydroxy-Δ5-C27-steroid dehydrogenase in pig tissues and subcellular fractions

378

Hepatic and extrahepatic malignancies in primary sclerosing cholangitis

379

Hepatic and Extra-hepatic Transcription of Inter-α-inhibitor Family Genes under Normal or Acute Inflammatory Conditions in Rat

380

Hepatic and intestinal cytochrome P450 and conjugase activities in rats treated with black tea theafulvins and theaflavins

381

Hepatic and Intestinal Schistosomiasis: Review

382

Hepatic and renal concentrations of 10 trace elements in crocodiles (Crocodylus niloticus) in the Kafue and Luangwa rivers in Zambia

383

Hepatic and renal concentrations of vitamins E and C in lead- and ethanol-exposed rats. An assessment of their involvement in the mechanisms of peroxidative damage

384

Hepatic and renal metallothionein induction by an oral equimolar dose of zinc, cadmium or mercury in mice

385

Hepatic and skeletal muscle glycogen metabolism in rats with short-term cholestasis

386

Hepatic and splenic sarcoidosis as a cause of hypercalcemia: a case report

387

Hepatic angiomyolipoma with minimal fat content: MR demonstration

388

Hepatic Angiomyolipoma: a Rarely Described Tumor

389

Hepatic angiomyolipoma: Demonstration by out of phase MRI

390

Hepatic angiomyolipoma: Value of proton (fat/water) chemical shift fast low angle shot (FLASH) MR imaging technique in detecting fatty tissue content

391

HEPATIC ANGIOSARCOMA: REPORT OF A CASE WITHOUT A HISTORY OF EXPOSURE TO ENVIRONMENTAL RISK FACTORS

392

Hepatic antioxidant enzymes and total glutathione of Cyprinus carpio exposed to three disinfectants, chlorine dioxide, sodium hypochlorite and peracetic acid, for superficial water potabilization

393

HEPATIC ANTIOXIDANT, OXIDATIVE STRESS an‎d HISTOPATHOLOGICAL CHANGES INDUCED BY NICOTINE IN A GENDER BASED STUDY IN ADULT RATS

394

Hepatic apolipoprotein and LDL receptor gene expression in the genetically hypercholesterolemic (RICO) rat Original Research Article

395

Hepatic Arterial Blood Flow Index Is Associated with the Degree of Liver Fibrosis in Patients with Chronic Hepatitis B Virus Infection

396

Hepatic arterial blood flow velocities: assessment by transcutaneous and intravascular Doppler sonography

397

Hepatic arterial Fotemustine chemotherapy in patients with liver metastases from cutaneous melanoma is as effective as in ocular melanoma

398

Hepatic arterial infusion chemotherapy for metastatic colorectal cancer: a concise overview

399

Hepatic Arterial Infusion Chemotherapy with Cisplatin for TACE-Refractory or -Ineligible Hepatocellular Carcinoma with Child-Pugh Score of 8 or Above

400

Hepatic arterial infusion for hepatic metastases from Colon Cancer

401

Hepatic arterial injection chemotherapy for hepatocellular carcinoma with epirubicin aqueous solution as numerous vesicles in iodinated poppy-seed oil microdroplets: clinical application of water-in-oil-in-water emulsion prepared using a membrane emulsifi

402

Hepatic arterial injection chemotherapy for hepatocellular carcinoma with epirubicin aqueous solution as numerous vesicles in iodinated poppy-seed oil microdroplets: clinical application of water-in-oil-in-water emulsion prepared using a membrane emulsifi

403

Hepatic arterial pulsatility index in cirrhosis: correlation with portal pressure

404

Hepatic Artery and Portal Vein Doppler Indexes in Non‑alcoholic Fatty Liver Disease Before and After Treatment to Prevent Unnecessary Health Care Costs

405

Hepatic Artery Aneurysms as a Rare but Important Cause of Abdominal Pain; a Case Series

406

Hepatic artery chemoembolization for management of patients with advanced metastatic carcinoid tumors

407

Hepatic artery chemotherapy and colorectal liver metastases

408

Hepatic artery chemotherapy and colorectal liver metastases

409

Hepatic artery chemotherapy and colorectal liver metastases

410

Hepatic artery chemotherapy and colorectal liver metastases

411

Hepatic artery embolisation with a novel radiopaque polymer causes extended liver necrosis in pigs due to occlusion of the concomitant portal vein

412

Hepatic artery infusion for liver metastases from colorectal cancer

413

Hepatic artery infusion of high-dose melphalan at reduced flow during isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: A clinical and pharmacologic evaluation

414

Hepatic artery ligation: a simple and safe technique to treat extrahepatic aneurysms of the hepatic artery

415

Hepatic artery malformations associated with a primary defect in intrahepatic bile duct development

416

Hepatic Artery Pseudoaneurysm ; Simple or Difficult to Diagnose

417

Hepatic artery pseudoaneurysm; a rare complication of Amoebic liver abscess

418

Hepatic Basolateral Plasma High-affinity Ca2+-RATPase is Inhibited by Nitric Oxide and Peroxynitrite Anion

419

Hepatic bile salt flux does not modulate level and activity of the sinusoidal Na+-taurocholate cotransporter (ntcp) in rats

420

Hepatic binding proteins translocating azo dye carcinogen metabolites from cytoplasm into nucleus in rats

421

Hepatic biomarkers of sediment-associated pollution in juvenile turbot, Scophthalmus maximus L.

422

Hepatic biomarkers of xenobiotic metabolism in eighteen marine fish from NW Mediterranean shelf and slope waters in relation to some of their biological and ecological variables

423

Hepatic biotransformation of alkylresorcinols is mediated via cytochrome P450 and β-oxidation: A proof of concept study

424

Hepatic bisegmentectomy 7–8 for a colorectal metastasis

425

Hepatic blood flow and splanchnic oxygen consumption in patients with hepatic encephalopathy before and after high-volume plasmapheresis

426

Hepatic blood flow responses to mechanical stimulation of the skin in anaesthetised rats

427

Hepatic branch vagotomy can block liver regeneration enhanced by ursodesoxycholic acid in 66% hepatectomized rats

428

HEPATIC CAPILLARIASIS IN CHILDREN: REPORT OF 3 CASES IN BRAZIL

429

Hepatic cavernous hemangiomas: Patterns of contrast enhancement on MR fluoroscopy imaging

430

Hepatic cell-specific ATP-binding cassette (ABC) transporter profiling identifies putative novel candidates for lipid homeostasis in mice

431

Hepatic cellular and tissue pathologic response in the mosquito fish, Gambusia affinis, to different time exposure of diethylnitrosamine

432

Hepatic Changes in the Freeze-Tolerant Turtle Chrysemys picta marginata in Response to Freezing and Thawing

433

Hepatic Choristoma: an Unexpected Finding During Cholecystectomy

434

Hepatic clearance of advanced glycation end products (AGEs)—myth or truth?

435

Hepatic CYP1A in winter flounder (Pleuronectes americanus) along the Northeast Coast: Results from the national benthic surveillance project

436

Hepatic CYP1A levels and EROD activity in English sole: biomonitoring of marine contaminants in Vancouver Harbour

437

Hepatic CYP450 gene expression, hematological and biochemical indices in Caspian roach (Rutilus caspius) induced by Endosulfan

438

Hepatic cytochrome P450 is directly inactivated by nitric oxide, not by inflammatory cytokines, in the early phase of endotoxemia

439

Hepatic cytochrome P450 reductase-null mice reveal a second microsomal reductase for squalene monooxygenase

440

Hepatic cytochrome P4501A and 7-ethoxyresorufin O-deethylase induction in mullet and common sole as an indicator of toxic organic pollution in Izmir Bay, Turkey

441

Hepatic differentiation of porcine induced pluripotent stem cells in vitro

442

Hepatic DNA adducts and production of mutagenic urine in 2,6-dinitrotoluene-treated B6C3F, male mice

443

Hepatic duct diverticulum

444

Hepatic dysfunction after left ventricular mechanical assist in patients with end-stage heart failure: role of inflammatory response and hepatic microcirculation

445

Hepatic dysfunction associated with atenolol

446

Hepatic Dysfunction in Ambulatory Patients With Heart Failure: Application of the MELD Scoring System for Outcome Prediction

447

Hepatic dysfunction in critically ill patients

448

Hepatic Effects of Endothelin: Metabolism of [125I]Endothelin-1 by Liver-Derived Cells

449

Hepatic elemental contents and antioxidant enzyme activities in Algerian mice (Mus spretus) inhabiting a mine area in central Portugal

450

Hepatic encephalopathy and ascites

451

Hepatic encephalopathy and ascites

452

Hepatic encephalopathy and nitric oxide

453

Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema?

454

Hepatic Encephalopathy Linked to COVID-19 in a Pediatric Case: A Rare Presentation of COVID-19

455

Hepatic encephalopathy: Clinical aspects and pathogenetic concept

456

Hepatic Encephalopathy: Early Diagnosis in Pediatric Patients With Cirrhosis

457

Hepatic Energy and Substrate Metabolism: A Possible Metabolic Basis for Early Nutritional Support in Cirrhotic Patients

458

Hepatic environment elicits monocyte differentiation into a dendritic cell subset directing Th2 response

459

Hepatic Epithelioid Hemangioendothelioma: A Review of Three Liver Transplant Recipients

460

Hepatic EROD Activity in Flounder (Platichthys flesus) as an Indicator of Contaminant Exposure in English Estuaries

461

Hepatic ethoxyresorufin O-deethylase (EROD) activity in flounder (Platichthys flesus) from contaminant impacted estuaries of the United Kingdom: continued monitoring 1999–2001

462

Hepatic expression of A Disintegrin And Metalloproteinase (ADAM) and ADAMs with thrombospondin motives (ADAM-TS) enzymes in patients with chronic liver diseases

463

Hepatic expression of regeneration marker genes following partial hepatectomy in the rat : Influence of 1,25-dihydroxyvitamin D3 in hypocalcemia

464

Hepatic expression profiling in smolting and adult coho salmon (Onchorhynchus kisutch)

465

Hepatic Failure After Bariatric Surgery: A Systematic Review

466

Hepatic Failure in a Young Woman Following Ingestion of Tribulus Terrestris

467

Hepatic Failure Related to Itraconazole Use Successfully Treated by Corticosteroids

468

Hepatic fatty acid metabolism in rats fed diets with different contents of C18 : 0, C18 : 1 cis and C18 : 1 trans isomers

469

Hepatic focal nodular hyperplasia in infant antenatally exposed to steroids

470

Hepatic free fatty acids accumulate in experimental steatohepatitis: Role of adaptive pathways

471

Hepatic fructose-metabolizing enzymes and related metabolites: role of dietary copper and gender

472

Hepatic functional reserve in patients with obstructive jaundice: An assessment by the redox tolerance test

473

Hepatic gene expression and lipid parameters in complement C3−/− mice that do not develop ethanol-induced steatosis

474

Hepatic gene expression and plasma albumin concentration related to outcome after attenuation of a congenital portosystemic shunt in dogs

475

Hepatic gene expression and prediction of therapy response in chronic hepatitis C patients

476

Hepatic gene expression profile associated with non-alcoholic steatohepatitis protection by S-nitroso-N-acetylcysteine in ob/ob mice

477

Hepatic gene expression profile in brown trout (Salmo trutta) exposed to traffic related contaminants Original Research Article

478

Hepatic gene expression profiling reveals perturbed calcium signaling in a mouse model lacking both LDL receptor and Apobec1 genes

479

Hepatic gene induction in murine bone marrow after hepatectomy

480

Hepatic glucose metabolism in humans—its role in health and disease

481

Hepatic glucose output response to nicotine and the underlying neural mechanism in rats

482

Hepatic Glutamate Dehydrogenase Activity and the Presence of Ammonia and Urea in the Circulatory Fluid of Channa Gachua in WaterRestricted Condition

483

Hepatic glutaminase—a special role in urea synthesis?

484

Hepatic glutamine metabolism

485

Hepatic glutamine metabolism during endotoxemia in neonatal rats

486

Hepatic glutathione in English sole (Pleuronectes vetulus): Response to complex mixtures of xenobiotics

487

Hepatic glutathione S-transferase activity in flounder collected from contaminated and reference sites along the Polish coast

488

Hepatic glutathione S-transferases from lamprey (Petromyzom marinus): purification and characterization

489

Hepatic granuloma mimicking recurrent lymphoma on ^18F-FDG PET/CT in a patient with primary mediastinal diffuse large B-cell lymphoma

490

Hepatic granulomas associated with brucellosis

491

Hepatic Health and Humoral Immunological Parameters of Common Carp (Cyprinus carpio) Fed Lactic Acid-supplemented Diets

492

Hepatic hemosiderosis in buffalo fish (Ictiobus spp.)

493

Hepatic histology in obese patients undergoing bariatric surgery

494

Hepatic histopathology in two populations of the mummichog, Fundulus heteroclitus

495

Hepatic hyaline globules in an Eclectus parrot (Eclectus roratus)

496

Hepatic hydatid cyst presenting as a cutaneous fistula

497

HEPATIC HYDROTHORAX WITH MODERATE ASCITIS IN A NIGERIAN

498

Hepatic hydrothorax: pathogenesis, diagnosis, and management

499

Hepatic imaging in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count), ,

500

Hepatic immunohistochemical staining with a monoclonal antibody against HCV-E2 to evaluate antiviral therapy and reinfection of liver grafts in hepatitis C viral infection

501

Hepatic Impact of Different Concentrations of Hibiscus rosa Zinc Oxide Nanoparticles on Rats

502

Hepatic inflammatory mass secondary to toothpick perforation of the stomach: triphasic CT appearances

503

Hepatic injury and vitamin A ingestion

504

Hepatic Involvement and Association with Prognosis in COVID-19 Patients: A Single-Centre Report from Iran

505

Hepatic Involvement in Dengue Fever in Children

506

Hepatic iron concentration does not predict response to standard and pegylated-IFN/ribavirin therapy in patients with chronic hepatitis C

507

Hepatic iron concentration, fibrosis and response to venesection associated with the A77D and V162del “loss of function” mutations in ferroportin disease

508

Hepatic iron metabolism gene expression profiles in HFE associated Hereditary Hemochromatosis

509

Hepatic iron overload and fibrosis in patients with beta thalassemia major after hematopoietic stem cell transplantation: A pilot study.

510

Hepatic iron overload and hepatocellular carcinoma

511

Hepatic iron overload in alcoholic liver disease: why does it occur and what is its role in pathogenesis?

512

Hepatic iron status and response to therapy in chronic viral hepatitis B and C: A preliminary report

513

Hepatic Ischemia and Reperfusion Injury and Trauma: Current Concepts

514

Hepatic ischemia secondary to hepatic artery ligation: MRI findings

515

Hepatic Ischemia/Reperfusion Injury Is Diminished by Atorvastatin in Wistar Rats

516

Hepatic ischemia-reperfusion injury

517

Hepatic ischemia-reperfusion injury

518

Hepatic levels of metal and metallothioneins in two commercial fish species of the Northern Iberian shelf

519

Hepatic lipase mediates an increase in selective uptake of high-density lipoprotein-associated cholesteryl esters by human Hep 3B hepatoma cells in culture Original Research Article

520

Hepatic lipase mediates lipoprotein uptake into cells via LDL receptor-related protein

521

Hepatic lipase mutations,elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease: The Copenhagen City Heart Study

522

Hepatic lipase promoter activity is reduced by the C-480T and G-216A substitutions present in the common LIPC gene variant, and is increased by Upstream Stimulatory Factor

523

Hepatic lipase promoter C-514T polymorphism influences serial changes in HDL cholesterol levels since childhood: the Bogalusa Heart Study

524

Hepatic lipid accumulation, altered very low density lipoprotein formation and apolipoprotein E deposition in apolipoprotein E3-Leiden transgenic mice

525

Hepatic lipid composition analysis using 3.0-T MR spectroscopy in a steatotic rat model

526

Hepatic lipidosis in a common Mynah (Acridotheres tristis) associated with pododermatitis and consumption of broiler pelleted feed

527

Hepatic lipogenic enzyme expression in pigs is affected by selection for decreased backfat thickness at constant intramuscular fat content

528

Hepatic Lobectomy-Case Report of Two Patients, Performed at Chittagong Medical College Hospital

529

Hepatic localisation of rat cysteine dioxygenase

530

Hepatic mesenchymal hamartoma with translocation involving chromosome band 19q13.4: a recurrent abnormality

531

Hepatic metabolism of sulfur amino acids in db/db mice

532

Hepatic metabolism, phase I and II biotransformation enzymes in Atlantic salmon (Salmo Salar, L) during a 12 week feeding period with graded levels of the synthetic antioxidant, ethoxyquin

533

Hepatic metallothionein as a biomarker for metal contamination: age effects and seasonal variation in European flounders (Pleuronectes flesus) from the Severn Estuary and Bristol Channel

534

Hepatic metallothionein concentrations in the golden grey mullet (Liza aurata) – Relationship with environmental metal concentrations in a metal-contaminated coastal system in Portugal

535

Hepatic metastasis complicated by abscess formation

536

Hepatic Microcirculatory Changes Induced by Hepatic Artery Embolization in Rats Original Investigation

537

Hepatic microvascular features in experimental cirrhosis: a structural and morphometrical study in CCl4-treated rats

538

Hepatic mitochondrial transport of glutathione: Studies in isolated rat liver mitochondria and H4IIE rat hepatoma cells

539

Hepatic mono-oxygenase induction in benthic flatfish sampled near coastal pulp mills in British Columbia

540

Hepatic mucosa-associated lymphoid tissue (MALT) lymphoma associated with hepatitis C

541

Hepatic multi-nodular focal fatty metamorphosis in acquired porphyria cutanea tarda: Sonographic, CT, and mri features

542

Hepatic mycotic aneurysms

543

Hepatic myelopathy Case report with review of the literature

544

Hepatic myelopathy with spastic paraparesis

545

Hepatic necroinflammation and severe liver fibrosis in patients with chronic hepatitis B with undetectable HBV DNA and persistently normal alanine aminotransferase

546

Hepatic Necrosis: A Main Presentation of Systemic Lupus Erythematosus in a Previously Healthy Woman

547

Hepatic nodules in liver transplantation candidates: MR imaging and underlying hepatic disease

548

Hepatic Osteodystrophy: a relationship between osteoporotic bone and chronic liver disease

549

Hepatic OV-6 expression in human liver disease and rat experiments: evidence for hepatic progenitor cells in man

550

Hepatic oval cell lines generate hepatocellular carcinoma following transfection with HBx gene and treatment with aflatoxin B1 in vivo

551

Hepatic overlap syndromes

552

Hepatic oxidative alterations in patients with extra-hepatic cholestasis. Effect of surgical drainage

553

Hepatic Oxidative Damages and Glucose Tolerance in Diabetic Rats Exposed to Repeated Oral Doses of Diazinon

554

Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients

555

Hepatic parenchymal enhancement at Gd-EOB-DTPA-enhanced MR imaging: correlation with morphological grading of severity in cirrhosis and chronic hepatitis

556

Hepatic parenchymal enhancement at Gd-EOB-DTPA-enhanced MR imaging: correlation with morphological grading of severity in cirrhosis chronic hepatitis

557

Hepatic phospholipids in alcoholic liver disease assessed by proton-decoupled 31P magnetic resonance spectroscopy

558

Hepatic portal venous gas

559

Hepatic portal venous gas: clinical significance of computed tomography findings

560

Hepatic production of VLDL1 but not VLDL2 is related to insulin resistance in normoglycaemic middle-aged subjects

561

Hepatic protection by perioperative metabolic support?

562

Hepatic protein synthesis rate of liver specimens as a predictor of viability in rat cold ischemia liver transplantation model

563

Hepatic Proteins and Inflammatory Markers in Rheumatoid Arthritis Patients

564

Hepatic pseudocapillarisation and atherosclerosis in ageing

565

Hepatic radiofrequency ablation using perfusion electrodes in a pig model: Effect of the Pringle manoeuvre

566

Hepatic reduction of insulin-like growth factor (IGF)-I and IGF binding protein-3 that results from fasting is not attenuated in genetically obese rats

567

Hepatic regeneration in insulin-like growth factor binding protein-1 transgenic mice

568

Hepatic release of interleukin-10 during cardiopulmonary bypass in steroid-pretreated patients, , , ,

569

Hepatic repopulation with stably transduced conditionally immortalized hepatocytes in the Gunn rat

570

Hepatic resection for hepatocellular carcinoma

571

Hepatic resection for hepatocellular carcinoma in Taiwan

572

Hepatic resection for large hepatocellular carcinoma

573

Hepatic resection for malignant melanoma

574

Hepatic resection for metastatic neuroendocrine carcinomas

575

Hepatic resection for recurrent metastatic ovarian cancer

576

Hepatic resection in breast cancer metastases: should it be considered standard treatment?

577

Hepatic resection in metastatic breast cancer: results and prognostic factors

578

Hepatic resection using stapling devices

579

Hepatic resection with vascular isolation and routine supraceliac aortic clamping

580

Hepatic retractor in an ex vivo model

581

Hepatic Rupture After Heimlich Maneuver

582

Hepatic Sarcodosis presenting as portal hypertension in a young boy

583

Hepatic sarcoidosis: MR appearances in patients with chronic liver disease

584

Hepatic Shock Differential Diagnosis and Risk Factors: A Review Article

585

Hepatic Sinusoidal Endothelial Cells Promote Hepatocyte Proliferation Early after Partial Hepatectomy in Rats

586

Hepatic sinusoidal-obstruction syndrome: toxicity of pyrrolizidine alkaloids

587

Hepatic Steatosis

588

Hepatic Steatosis Alleviated by a Novel Metformin and Quercetin Combination Activating Autophagy Through the cAMP/AMPK/SIRT1 Pathway

589

Hepatic Steatosis among Obese Children and Adolescents

590

Hepatic Steatosis and Fibrosis in Type 2 Diabetes: A Risk-Based Approach to Targeted Screening

591

Hepatic steatosis and insulin resistance: Does etiology make a difference?

592

Hepatic Steatosis and Related Factors in Obese Children Attending National Nutritional Institute

593

Hepatic steatosis and very low density lipoprotein secretion: the involvement of apolipoprotein E

594

Hepatic steatosis in chronic hepatitis B and C: Predictors, distribution and effect on fibrosis

595

Hepatic steatosis in HIV/HCV co-infected patients: Correlates, efficacy and outcomes of anti-HCV therapy: A paired liver biopsy study

596

Hepatic Steatosis in Iranian Patients with Chronic Hepatitis C

597

Hepatic steatosis is associated with a greater prevalence of coronary artery calcification in asymptomatic men

598

Hepatic steatosis: An experimental model for quantification

599

Hepatic stellate (ITO) cells: expanding roles for a liver-specific pericyte

600

Hepatic stellate cell activation in genetic haemochromatosis : Lobular distribution, effect of increasing hepatic iron and response to phlebotomy

601

Hepatic stellate cell activation occurs in nonalcoholic steatohepatitis

602

Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis

603

Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers

604

Hepatic stellate cells (Ito-cells) but not collagen IV may partly be responsible for lower portal pressure after reversing secondary biliary cirrhosis in the rat

605

Hepatic stellate cells and the regulation of liver inflammation

606

Hepatic stellate cells are an important cellular site for β-carotene conversion to retinoid

607

Hepatic stellate cells become susceptible to fas-ligand induced apoptosis during transformation to myofibroblasts

608

Hepatic stellate cells do not derive from the neural crest

609

Hepatic stellate cells in human schistosomiasis mansoni: A comparative immunohistochemical study with liver cirrhosis

610

HEPATIC STELLATE CELLS IN THE CONTEXT OF LIVER FIBROSIS

611

Hepatic stem cells

612

Hepatic Stem-like Phenotype and Interplay of Wnt/β-Catenin and Myc Signaling in Aggressive Childhood Liver Cancer

613

Hepatic stress in hereditary tyrosinemia type 1 (HT1) activates the AKT survival pathway in the fah−/− knockout mice model

614

Hepatic tissue damage induced in Meriones ungliculatus due to infection with Babesia divergens-infected erythrocytes

615

Hepatic Tissue Engineering Using Scaffolds: State of the Art

616

Hepatic Toxocariasis in a Child: ACase Report from Shiraz, Southern Iran

617

Hepatic triacylglycerols and serum non-esterified fatty acids (NEFA) variations in indigenous water buffalo (Bubalus bubalis) in the province of Khuzestan, Iran

618

Hepatic tumor necrosis factors production and distant organ dysfunction in a murine model of obstructive jaundice

619

Hepatic tumours in childhood: An experience at the Children Hospital and Institute of Child Health, Lahore

620

Hepatic undifferentiated embryonal sarcoma: malignant evolution of mesenchymal hamartoma? Study of one case with immunohistochemical and flow cytometric emphasis

621

Hepatic vagotomy inhibits proliferation of hepatic stellate cells in rats with acute hepatitis

622

Hepatic vascular calcification: An early second trimester sonographic feature of idiopathic infantile arterial calcinosis

623

Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: Doppler sonographic screening in a large family

624

Hepatic vein to the azygous vein anastomosis for pulmonary arteriovenous fistulae

625

Hepatic vein velocities in children with right ventricular hypertension

626

Hepatic vein waveform in liver cirrhosis: Correlation with Child’s class and size of varices

627

Hepatic veno-occlusive disease with immunodeficiency (VODI): First reported case in the U.S. and identification of a unique mutation in Sp110

628

Hepatic Venous Malformation After Modified Fontan Procedure With Partial Hepatic Vein Exclusion

629

Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy

630

Hepatic viral infections in Yemen between 2000-2005

631

Hepatic von Meyenburg complex simulating biliary cystadenocarcinoma

632

Hepatic, Renal and Cardiovascular Biomarker Variability in Type 2 Diabetes Mellitus Patients with Poor Glycemic Control

633

Hepaticocholecystoduodenostomy compared with Roux-en-y choledochojejunostomy for decompression of the biliary tract

634

Hepatiti C and Ocular urface Dieae Original Reearch Article

635

Hepatitis A 2004 Vaccination in Children: Methods and Findings of a Survey in Two States Original Research Article

636

Hepatitis A and B immunization in persons being evaluated for sexually transmitted diseases

637

Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus

638

Hepatitis A and E: not to be forgotten

639

Hepatitis A and vigorous physical activity

640

Hepatitis A booster vaccination: is there a need?

641

Hepatitis A Chronic Immunity in Iran: A Geographic Information System-Based Study

642

Hepatitis A Chronic Immunity: A Population-Based Seroprevalence Study in Fars Province, Southern Iran

643

Hepatitis A IgG seropositivity and coronary atherosclerosis assessed by angiography

644

HEPATITIS A IN LATIN AMERICA: A CHANGING EPIDEMIOLOGIC PATTERN

645

Hepatitis A in the Eastern Mediterranean Region: A Review on the Prevalence

646

Hepatitis A Infection Presented with Pancytopenia, a Case Series in Children

647

Hepatitis A Is a Health Hazard for Iranian Pilgrims Who Go to Holly Karbala: A Preliminary Report

648

Hepatitis A linked to clotting factors in USA

649

Hepatitis A Prevention Strategies, Haiti Case: Should Rescuers Be Immunized

650

Hepatitis A Seropositivity among First-Year Students of the Medical University in Isfahan, Iran

651

Hepatitis A seropositivity among newly admitted medical students of Isfahan, Kermanshah, and Hamedan: A seroprevalence study

652

Hepatitis a seroprevalence among young adults: Effects of ACIP immunization recommendations

653

Hepatitis A Seroprevalence and Associated Risk Factors: A Community-based Cross-sectional Study in Shahrekord, Iran

654

Hepatitis A Vaccination among Thai Medical Students: A Questionnaire Study

655

Hepatitis A vaccine failure

656

Hepatitis A vaccine for Israeli children

657

Hepatitis A vaccine for secondary hepatitis A infection

658

Hepatitis A vaccine for secondary hepatitis A infection

659

Hepatitis A vaccine for secondary hepatitis A infection

660

Hepatitis A vaccine for secondary hepatitis A infection

661

Hepatitis A vaccine for secondary hepatitis A infection

662

Hepatitis A vaccine in the last-minute traveler

663

Hepatitis A virus – a general overview

664

Hepatitis A Virus and Coronary Artery Diseases

665

Hepatitis A Virus and Hepatitis E Virus Seroprevalence Among Blood Donors in Tehran, Iran

666

Hepatitis A virus in environmental water samples from the Amazon Basin

667

Hepatitis A Virus Infection

668

Hepatitis A virus infection suppresses hepatitis C virus replication and may lead to clearance of HCV

669

Hepatitis A Virus Infection, Vaccination and Iranian Healthcare Workers

670

Hepatitis A virus infection: Is it an important hazard to public health?

671

Hepatitis A Virus Seropositivity in Nurses and Paramedical Personnel at a University Hospital in North Iran

672

Hepatitis A virus vaccination in Iranian soldiers needs more attention

673

Hepatitis A Virus: Is Vaccination Necessary in Middle East?

674

Hepatitis A Virus: Seroepidemiological Study in Fars Province

675

Hepatitis A with Pleural Effusion, Ascites and Acalculous Cholecystitis

676

Hepatitis after intravenous buprenorphine misuse in heroin addicts

677

Hepatitis agent cloned and designated hepatitis G virus

678

Hepatitis and community: The current scenario and a roadmap for 2030

679

Hepatitis and death following vaccination with 17D-204 yellow fever vaccine

680

Hepatitis and HIV screening, education, and treatment for adults with serious mental illness

681

Hepatitis Awareness Bus: A Model for Finding Unknown Hepatitis B and C Infections

682

Hepatitis B among homeless and other impoverished US military veterans in residential care in Los Angeles

683

Hepatitis B and C among Patients Infected with Human Immunodeficiency Virus in Isfahan, Iran: Seroprevalence and Associated Factors

684

Hepatitis B and C among thalassemiac patients in Iran: A multicenter study

685

Hepatitis B and C among women with illegal social behavior in Isfahan, Iran: Seroprevalence and associated factors

686

Hepatitis B and C and the Role of Non-specialists on Disease Elimination

687

Hepatitis B and C in HIV-infected patients : Prevalence and prognostic value

688

Hepatitis B and C infection in first-time blood donors in Karachi – a possible subgroup for sentinel surveillance

689

Hepatitis B and C Infections Among Pediatric Patients with Sickle Cell Disease at a Tertiary Hospital in Nigeria

690

Hepatitis B and C Infections and Different Genotypes of HCV Among Sickle Cell Anemia Patients in Ahvaz, South-Western Iran

691

Hepatitis B and C Infections in Hamadan Province during 2004-2009

692

Hepatitis B and C knowledge among Saudi dental patients

693

Hepatitis B and C viral infection: prevalence, knowledge, attitude and practice among barbers and clients in Gharbia governorate, Egypt

694

Hepatitis B and C Viral Infection: Prevalence, Knowledge, Attitude, Practice, and Occupational Exposure among Healthcare Workers of Jimma University Medical Center, Southwest Ethiopia

695

Hepatitis B and C viral infections in chronic liver disease: a populationbased study in Qatar

696

Hepatitis B and C virus hepatocarcinogenesis: Lessons learned and future challenges

697

Hepatitis B and C virus infection and the risk of atherosclerosis in a general population

698

Hepatitis B and C: An alarming situation in Southern part of Khyber Pakhtunkhwa, Pakistan

699

Hepatitis B and C: Prevention is better than cure

700

Hepatitis B and health-care workers

701

Hepatitis B and health-care workers

702

Hepatitis B and health-care workers

703

Hepatitis B and health-care workers

704

Hepatitis B and Hepatitis C in Patients with Inherited Disorders of Hemoglobin in Sistan and Baluchistan Province, Iran

705

Hepatitis B and Hepatitis C Seroprevalence in the Center of Sanliurfa Province From Southeastern Anatolia Region and Related Risk Factors

706

Hepatitis B and hepatitis C virus prevalence among dialysis patients in Bahrain and Saudi Arabia: A survey by serologic and molecular methods

707

Hepatitis B- and Hepatitis C-Related Hepatocellular Carcinomas in the United States: Similarities and Differences

708

Hepatitis B and HIV co-infection is still treated using lamivudine-only antiretroviral therapy combination in Uganda

709

Hepatitis B and its Relationship With Oxidative Stress

710

Hepatitis B associated liver failure following bone marrow transplantation

711

Hepatitis B Awareness and Knowledge in Asian Communities in British Columbia

712

Hepatitis B Birth Dose among Children in District 2 Hospital, Ho Chi Minh City, Vietnam: Prevalence and Associated Factors

713

Hepatitis B booster vaccination for healthcare workers

714

Hepatitis B Core Antibody ImmunoglobulinMin Blood Donors With a History of Hepatitis B Virus Infection

715

HEPATITIS B e ANTIGEN AND THE RISK OF HEPATOCELLULAR CARCINOMA

716

Hepatitis B e Antigen-Negative Chronic Hepatitis B

717

Hepatitis B envelope protein mutants

718

Hepatitis B epidemiology and cultural practices in Amerindian populations of Amazonia: The Tupí-Mondé and the Xavánte from Brazil

719

Hepatitis B genotypes and the response to interferon therapy

720

Hepatitis B Genotypes in Iran

721

Hepatitis B genotypes in patients with acute hepatitis B virus infection

722

Hepatitis B Immune Globulin in Liver Transplantation Prophylaxis: An Update

723

Hepatitis B immunisation in chronically transfused recipients

724

Hepatitis B immunisation in Singapore

725

Hepatitis B Immunization in Health Care Workers: Needs and Opportunities

726

Hepatitis B immunization in postpartum women

727

Hepatitis B in a high prevalence New Zealand population: A mathematical model applied to infection control policy

728

Hepatitis B in China

729

Hepatitis B infection among Asian American Pacific Islanders in the Rocky Mountain area

730

Hepatitis B Infection among Korean Americans in Colorado: Evidence of the Need for Serologic Testing and Vaccination

731

Hepatitis B infection among Nigerian children admitted to a children’s emergency room

732

Hepatitis B Infection among Patients Receiving Chronic Hemodialysis at the Royal Medical Services in Jordan

733

Hepatitis B Infection during Renal Replacement Therapy

734

Hepatitis B infection in Eastern Indian families: Need for screening of adult siblings and mothers of adult index cases

735

Hepatitis B infection in Eastern Mediterranean Region: challenges and the way forward

736

Hepatitis B Infection in Hemodialysis Patients in Tehran Province, Iran

737

Hepatitis B infection is highly endemic in Uganda: findings from a national serosurvey

738

Hepatitis B infection: Pathogenesis and management

739

Hepatitis B Infection: Prevalence and Response to Vaccination among Health Care Workers in Babol, Northern Iran

740

Hepatitis B is a Serious Health Problem in Some Parts of Iran; Sistan and Baluchestan Province

741

Hepatitis B Knowledge Among Healthy Volunteers in Duhok City, Kurdistan Region, Iraq

742

Hepatitis B Knowledge Among Iranian Adolescents: A National Survey

743

Hepatitis B or hepatitis C and human immunodeficiency virus infection

744

Hepatitis B pregenomic RNA splicing—The products, the regulatory mechanisms and its biological significance

745

Hepatitis B prevalence among workers in Turkey at low risk for hepatitis B exposure

746

Hepatitis B Prevention Education and Afghan Immigrant Students

747

Hepatitis B reactivation after lamivudine

748

Hepatitis B Reactivation During Immunosuppressive Therapy or Cancer Chemotherapy, Management, and Prevention: A Comprehensive Review

749

Hepatitis B Recurrence After Liver Transplantation: A Single Center Experiences and Review the Literature

750

Hepatitis B resistance in Iran

751

Hepatitis B Seroconversion Rate After Primary Immunization Series with Newly Introduced Pentavalent Vaccine: A Report of Local Study in Alborz Province, Iran, 2016

752

Hepatitis B seromarkers, hepatitis C antibody, and risk behaviors in married couples, a bordered province of western Thailand

753

Hepatitis B Seroprevalence and Risk Factors in Adult Population of Chaharmahal and Bakhtiari Province in 2013

754

Hepatitis B Seroprevalence and the Relationship Between Being Hepatitis B Vaccinated and Infected with Social Determinants of Health: Manisa, 2014

755

Hepatitis B Splice-Generated Protein Antibodies in Syrian Chronic Hepatitis B Patients: Incidence and Significance

756

Hepatitis B Stigma and Knowledge among Vietnamese in Ho Chi Minh City and Chicago

757

Hepatitis B surface antibody purification with hepatitis B surface antibody imprinted poly(hydroxyethyl methacrylate-N-methacryloyl-l-tyrosine methyl ester) particles

758

Hepatitis B surface antibody response of household contacts of hepatitis B virus carriers in Palestine

759

Hepatitis B Surface Antigen and Viral DNA Detection and Prevalence in Nigeria

760

Hepatitis B surface antigen carrier rate in unvaccinated and vaccinated children with thalassaemia major at Bahawal Victoria Hospital, Bahawalpur, Pakistan

761

HEPATITIS B SURFACE ANTIGEN DISAPPEARANCE AND HEPATITIS B SURFACE ANTIGEN SUBTYPE: A PROSPECTIVE, LONG-TERM, FOLLOW-UP STUDY OF JAPANESE RESIDENTS OF OKINAWA, JAPAN WITH CHRONIC HEPATITIS B VIRUS INFECTION

762

Hepatitis B Surface Antigen Prevalence among Pregnant Women in Rafsanjan City, Iran, 2003

763

Hepatitis B surface antigen prevalence in pregnant women: A cross‑sectional survey in Iran

764

Hepatitis B surface antigen, hepatitis C and HIV antibodies in a low-risk blood donor group, Nigeria

765

Hepatitis B Surface Antigen, Hepatitis C Virus Antibody, Body Mass Index, and Alcohol Drinking among Workers with Elevated Serum Alanine Aminotransferase

766

Hepatitis B surface antigenemia (HBsAg) among pregnant women in southern Nigeria

767

Hepatitis B surface antigen-negative, but HBV DNA-positive patients in Bangladesh

768

Hepatitis B testing among Vietnamese American men

769

Hepatitis B transmission from contaminated cryopreservation tank

770

Hepatitis B vaccination after liver transplantation as a strategy to discontinue prophylaxis with hepatitis B immune globulin

771

Hepatitis B vaccination among primary health care workers in Northwest Pakistan

772

HEPATITIS B VACCINATION AND INFANTILE IDIOPATHIC THROMBOCYTOPENIC PURPURA

773

Hepatitis B vaccination coverage among Iranian children aged 15–26 months in 2006

774

Hepatitis B Vaccination Coverage Among Iranian Medical Students and Nursing Staff

775

Hepatitis B Vaccination Coverage and Its Associated Factors in Nurses of Imam Reza (AS) Hospital in Kermanshah

776

Hepatitis B Vaccination Coverage and Sharp Injuries Among Healthcare Workers in Hamadan, Iran

777

Hepatitis B vaccination coverage in medical students at a medical college of Mirpurkhas

778

Hepatitis B Vaccination Coverage, HBS-Ab Level and its Related Factors among Dentistry and Medical Students

779

Hepatitis B Vaccination Efficacy in Iranian Healthcare Workers: A Meta-Analysis Study

780

Hepatitis B vaccination follow-up

781

Hepatitis B Vaccination in Bangladesh: a Suggestion Based on Current Evidence

782

Hepatitis B Vaccination in Chronic Kidney Disease: Review of Evidence in Non-Dialyzed Patients

783

Hepatitis B vaccination in correctional health care workers

784

Hepatitis B vaccination in correctional health care workers

785

Hepatitis B vaccination of babies in Melanesia

786

Hepatitis B vaccination of health care workers in Saudi Arabia

787

Hepatitis B vaccination program at a New York City hospital: Seroprevalence, seroconversion, and declination, ,

788

Hepatitis B Vaccination Reliability in Celiac Disease

789

Hepatitis B Vaccination Status in Dental Practitioners: Local Horrifying Report, National Considerable Issue, and Global Health Impact

790

Hepatitis B vaccination strategy for newborn babies

791

Hepatitis B Vaccination: Needs a Revision

792

Hepatitis B vaccination: to boost or not to boost?

793

Hepatitis B Vaccine Acceptability among Nurses: A Theory Based Conceptualization

794

Hepatitis B vaccine and anti-HBs complex as approach for vaccine therapy

795

Hepatitis B vaccine booster dose: Low-dose recombinant hepatitis B vaccines as a booster dose,

796

Hepatitis B vaccine boosting among young healthy adults

797

Hepatitis B vaccine boosting: the debate continues

798

Hepatitis B Vaccine Coverage and the Immune Response in Children under ten years old in Sana’a, Yemen

799

Hepatitis B vaccine in patients on haemodialysis

800

Hepatitis B vaccine, hepatitis C virus infection, and haemodialysis

801

Hepatitis B Vaccine: Immunity, Efficacy and Types.

802

Hepatitis B Viral DNA Among HBs Antigen Negative Healthy Blood Donors

803

Hepatitis B viral genotypes and lamivudine resistance

804

Hepatitis B Viral Markers in Surface Antigen Negative Blood Donors: The Need to Look Beyond Antibody Negativity

805

Hepatitis B viral resistance: mechanisms and diagnosis

806

Hepatitis B viral X protein interacts with tumor suppressor adenomatous polyposis coli to activate Wnt/β-catenin signaling

807

Hepatitis B Virus (HBV) and Occult Hepatitis B Virus (OBI) in Hemodialysis Patients: An Epidemiological Observational Study in Kerman, Iran (2022-2023)

808

Hepatitis B virus (HBV) DNA assays (methods and practical use) and viral kinetics

809

Hepatitis B Virus (HBV) Infection among Pregnant Women in Makurdi, Nigeria

810

Hepatitis B virus (HBV) vaccine-induced escape mutants of HBV S gene among children from Qidong area, China

811

Hepatitis B Virus / Human Immunodeficiency Virus Co-Infection and Its Hepatocarcinogenic Potential in Sub-Saharan Black Africans

812

Hepatitis B virus among maintainence haemodialysis patients: A report from Karachi, Pakistan

813

Hepatitis B virus among schoolchildren in an endemic area in Egypt over a decade: Impact of hepatitis B vaccine

814

Hepatitis B virus and celiac disease

815

Hepatitis B Virus and Cytomegalovirus Infections Disrupt Sperm Parameters in Males through Decreasing Mitochondrial Membrane Potential: A Case-control Study

816

Hepatitis B virus and hepatocellular carcinoma

817

Hepatitis B virus and HIV infection among patients with primary hepatocellular carcinoma in Kampala, Uganda

818

Hepatitis B virus and host factors

819

Hepatitis B Virus and Malaria Co-infection Causing Significant Changes in Hematological and Liver Function Indices in a Cohort of Subjects in Ilorin, Nigeria

820

Hepatitis B Virus Antibody Levels in High-Risk Health Care Workers

821

Hepatitis B virus clearance by transplantation of bone marrow from hepatitis B immunised donor

822

Hepatitis B Virus Complications of Pregnancy After Kidney Transplantation

823

Hepatitis B Virus Core Promoter Mutations in Patients With Chronic Hepatitis B and Hepatocellular Carcinoma in Bucharest, Romania

824

Hepatitis B virus DNA in sera and liver tissue of HBsAg negative patients with chronic hepatitis C

825

Hepatitis B Virus DNA is Absent in Lebanese Blood Donors Who Are Positive for Both Anti-Hbc and Anti-Hbs Antibodies

826

Hepatitis B virus DNA level Among the Seropositive Afghan Immigrants, Southern Iran

827

Hepatitis B virus DNA level as predictor of response to therapy with interferon-alpha-2b (PDferon) in chronic hepatitis B infection

828

Hepatitis B virus E antigen but not HBV core is presented to specific CD4+ T cells via the endogenous antigen processing pathway

829

Hepatitis B virus enhances interleukin-27 expression both in vivo and in vitro

830

Hepatitis B virus enhances transduction of human hepatocytes by SV40-based vectors

831

Hepatitis B virus enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) cytotoxicity by increasing TRAIL-R1/death receptor 4 expression

832

Hepatitis B virus genetic diversity in Latin America

833

Hepatitis B virus genetic variability and evolution

834

Hepatitis B Virus Genome Asymmetry in Hepatocellular Carcinoma

835

Hepatitis B Virus Genotype B and High Expression of Interferon Alpha Receptor β Subunit are Associated With Better Response to Pegylated Interferon Alpha 2a in Chinese Patients With Chronic Hepatitis B Infection

836

Hepatitis B Virus Genotype G Infection in a Turkish Patient Undergoing Hemodialysis Therapy

837

Hepatitis B virus genotypes and extrahepatic manifestations

838

Hepatitis B Virus Genotypes Distribution with HBsAg Positive in the North of Iran (Mazandaran) During 2011-2014

839

Hepatitis B Virus Genotypes in Eastern Azerbaijan, Northwest Iran

840

Hepatitis B virus genotypes, core gene variability and ethnicity in the Pacific region

841

Hepatitis B Virus Genotypes, Epidemiological Characteristics, and Clinical Presentation of HBV Chronic Infection in Immigrant Populations Living in Southern Italy

842

Hepatitis B Virus Genotyping Among Chronic Hepatitis B Individuals With Resistance to Lamivudine in Shahrekord, Iran

843

Hepatitis B Virus Genotyping Among Chronic Hepatitis B Individuals With Resistance to Lamivudine in Shahrekord, Iran

844

Hepatitis B virus Genotyping Among Patients With Cirrhosis

845

Hepatitis B virus in cervicovaginal lavage samples of pregnant women in Gorgan city, north of Iran

846

Hepatitis B virus induced hepatocellular carcinoma

847

Hepatitis B Virus Infection among Health Colleges’ Students in Aseer Region, Southwestern Saudi Arabia

848

Hepatitis B virus infection among staff in three hospitals in Khartoum, Sudan, 2006–07

849

Hepatitis B Virus Infection and Exposure Among Foreign-Born Asian Americans in the U.S.

850

Hepatitis B Virus Infection and Oral Lichen Planus: A Report from Northeast of Iran

851

Hepatitis B Virus Infection and Oral Lichen Planus: A Report from Northeast of Iran

852

Hepatitis B virus infection contributes to oxidative stress in a population exposed to aflatoxin B1 and high-risk for hepatocellular carcinoma

853

Hepatitis B Virus Infection during Pregnancy: Transmission and Prevention

854

Hepatitis B Virus Infection Flare Induced Acute-on-chronic Liver Failure After COVID-19 Vaccination: A Case Report

855

HEPATITIS B VIRUS INFECTION IN AN ANTI-HBC NEGATIVE PATIENT: A CASE REPORT

856

Hepatitis B virus infection in Iran

857

Hepatitis B Virus Infection in Iran: A Systematic Review

858

Hepatitis B Virus Infection in Iran: Current Knowledge, Future Plans

859

Hepatitis B Virus Infection in Iranian Hemodialysis Patients A Systematic Review and Meta-Analysis

860

Hepatitis B virus infection in lymphatic tissues in inactive hepatitis B carriers

861

Hepatitis B Virus Infection in Patients with Blood Disorders: A Concise Review in Pediatric S

862

Hepatitis B Virus Infection in the General Population of Iran: An Updated Systematic Review and Meta-Analysis

863

Hepatitis B Virus Infection in Vaccinated Children and Adolescents with HBsAg-positive Parents: Is Routine Vaccination Sufficient?

864

Hepatitis B Virus Infection Serology and the Associated Risk Factors Among Patients With HIV in Shiraz, Iran

865

Hepatitis B virus infection without immunological markers after open-heart surgery

866

Hepatitis B virus infection: Current status

867

Hepatitis B Virus Infection; A Vanishing Disease in Iranian Children

868

Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis

869

Hepatitis B virus large surface protein: function and fame

870

Hepatitis B virus mutants and efficacy of vaccination

871

Hepatitis B virus mutants and efficacy of vaccination

872

Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation

873

Hepatitis B virus precore mutants in serum and liver of Southern African Blacks with hepatocellular carcinoma

874

Hepatitis B Virus PreS Variant and Hepatocellular Carcinoma

875

Hepatitis B Virus preS2 Domain Promotes Angiogenesis in Hepatocellular Carcinoma via Transcriptional Activation of VEGFA Promoter

876

Hepatitis B virus quasispecies susceptibility to entecavir confirms the relationship between genotypic resistance and patient virologic response

877

Hepatitis B Virus Reactivation Potential Risk Factors in Hepatocellular Carcinoma via Transcatheter Arterial Chemoembolization: A Retrospective Research

878

Hepatitis B virus replication and viral antigen synthesis in hepatocyte lines derived from normal human liver

879

Hepatitis B virus resistance to antivirals: clinical implications and management

880

Hepatitis B Virus Screening and Real Life Data in Patients with Solid Tumor Receiving Chemotherapy

881

Hepatitis B virus sequence changes evolving in liver transplant recipients with fulminant hepatitis

882

Hepatitis B virus seropositivity is not associated with increased risk of carotid atherosclerosis in Taiwanese

883

Hepatitis B Virus Should not be Forget in Health Care Worker

884

Hepatitis B virus subtypes and lamivudine resistance

885

Hepatitis B Virus Surface Antigen (HBsAg) Mutations Are Rare but Clustered in Immune Epitopes in Chronic Carriers from Sistan-Balouchestan Province, Iran

886

Hepatitis B Virus Surface Antigen Variants Clustered Within Immune Epitopes in Chronic Hepatitis B Carriers from Hormozgan Province, South of Iran

887

Hepatitis B virus transmission and hepatocarcinogenesis: a 9 year retrospective cohort of 13 676 relatives with hepatocellular carcinoma

888

Hepatitis B Virus Vaccination in Hemodialysis Patients: A Necessity for Individualizing of Immunization?

889

Hepatitis B Virus Vaccine immune response in Egyptian children 15-17 years after primary immunization; should we provide a booster dose?

890

Hepatitis B virus viral dynamics: effects of drug dose and baseline alanine aminotransferase

891

Hepatitis B virus X antigen and aflatoxin B1 synergistically cause hepatitis, steatosis and liver hyperplasia in transgenic zebrafish

892

Hepatitis B virus X gene is implicated in liver carcinogenesis

893

Hepatitis B virus X mediates podocyte pyroptosis by regulating the ROS/NLRP3 signaling pathway in hepatitis B virus-associated glomerulonephritis

894

Hepatitis B virus X protein (HBx) activates ATF6 and IRE1-XBP1 pathways of unfolded protein response

895

Hepatitis B virus X protein induced expression of interleukin 18 (IL-18): a potential mechanism for liver injury caused by hepatitis B virus (HBV) infection

896

Hepatitis B virus X protein induces apoptosis in hepatoma cells through inhibiting Bcl-xL expression

897

Hepatitis B virus X protein interacts with NF-KB inhibitors

898

Hepatitis B virus X protein overcomes stress-induced premature senescence by repressing p16INK4a expression via DNA methylation

899

Hepatitis B virus X protein promotes cell migration by inducing matrix metalloproteinase-3

900

Hepatitis B virus X protein stimulates the Hedgehog–Gli activation through protein stabilization and nuclear localization of Gli1 in liver cancer cells

901

Hepatitis B Virus X Protein Up-Regulates AKR1C1 Expression Through Nuclear Factor-Y in Human Hepatocarcinoma Cells

902

Hepatitis B virus YMDD-motif mutations with emergence of lamivudine-resistant mutants: a threat to recovery

903

Hepatitis B Virus, Hepatitis C Virus Markers and Serum Alanine Amino-Transferase (ALT) Levels, in a Young Adult Population of Sylhet District

904

Hepatitis B Virus-associated Glomerulonephritis

905

Hepatitis B Virus-associated Nephropathy An International Data Analysis

906

Hepatitis B viruses and cancerogenesis

907

Hepatitis B viruses: Reverse transcription a different way

908

Hepatitis B virus-induced hepatocellular carcinoma

909

Hepatitis B virus-infected cells can be eliminated by the cytotoxic T cell-mediated immune reaction. Fas ligand, recently detected on the surface of cytotoxic T cell, is thought to induce cells to apoptosis by adhering to Fas antigen. Aims/Methods: To eva

910

Hepatitis B virus-related vasculitis manifesting as severe peripheral neuropathy following influenza vaccination

911

Hepatitis B, C virus co-infection and behavioral risks in HIV-positive patients in southern Iran

912

Hepatitis B, Hepatitis C and HIV seroprevalence in critically ill emergency medicine department patients in a tertiary inner city hospital in Istanbul, Turkey

913

Hepatitis B, Hepatitis C and Human Immunodeficiency Virus Seropositivity Among Children in Kabul, Afghanistan: A Cross-Sectional Study

914

Hepatitis B, Hepatitis C, and Human Immune deficiency Virus Seroconversion Positivity Rates and Their Potential Risk Factors Among Patients on Maintenance Hemodialysis in Cameroon

915

Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus Infection in Multi-Transfused Thalassemic Patients, Kermanshah, Iran, 2015

916

Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus Infection in Multi-Transfused Thalassemic Patients, Kermanshah, Iran, 2015

917

Hepatitis B, hepatitis C, HIV, and VDRL seroprevalence of blood donors in Mersin, Turkey*

918

Hepatitis B: Epidemiology and prevalence in Iran, during 2002-2014

919

Hepatitis B: Knowledge, Vaccine Situation and Seroconversion of Dentistry Students of a Public University

920

Hepatitis B: Reflections on the current approach to antiviral therapy

921

Hepatitis BMarkers in Isfahan, Central Iran: APopulation-Based Study

922

Hepatitis B-Related Concerns and Anxieties Among People With Chronic Hepatitis B in Australia

923

Hepatitis C (HCV) Viremic Rate and its Correlation to Demographic Factors among HCV Confirmed Iranian Blood Donors

924

Hepatitis C among Hemodialysis Patients: A Review on Epidemiologic, Diagnostic, and Therapeutic Features

925

Hepatitis C among Hemodialysis Patients: Impact of Strict Adherence to Universal Precautions

926

Hepatitis C among Intravenous Drug Users in Isfahan, Iran: A Study of Seroprevalence and Risk Factors

927

HEPATITIS C AMONG YOUNG MALE OFFENDERS ADMITTED TO THE CENTRAL JAIL, LAHORE

928

Hepatitis C and alcohol

929

Hepatitis C and B-cell lymphoma: the hemato-hepatologist linkage

930

Hepatitis C and B-cell non-Hodgkin’s lymphoma: a geographicallyvariable association?

931

Hepatitis C and blood transfusion among children attending the Sickle Cell Clinic at Mulago Hospital, Uganda

932

Hepatitis C and Depression

933

Hepatitis C and G Virus Infection Prevalence Among Hemodialysis Patients and Associated Risk Factors in the Hormozgan Province of Southern Iran

934

Hepatitis C and hepatitis B seroprevalence and associated risk factors in hemodialysis patients in Guilan province, north of Iran

935

Hepatitis C and Hepatitis B Virus Infection: Epidemiology and Risk Factors in a Large Cohort of Pregnant Women in Lorestan, West of Iran

936

Hepatitis C and HIV infection: biological, clinical, and therapeutic implications

937

Hepatitis C and hospital outcomes in patients admitted with alcohol-related problems

938

Hepatitis C and liver transplantation

939

Hepatitis C and pulmonary fibrosis

940

Hepatitis C and renal failure

941

Hepatitis C and Steatosis

942

Hepatitis C and Teens

943

Hepatitis C and Teens

944

Hepatitis C and the correctional population

945

Hepatitis C and the heart: to beat or not to beat

946

Hepatitis C and thyroid autoimmunity: is there a link?

947

Hepatitis C and Why the Treatment is Needed Now? The Summary Report From the Cross-Border Symposium of the 5th Tehran Hepatitis Congress May 2013

948

Hepatitis C at work place: A survey of Occupational Health and Safety Knowledge and Practice in Beauty Therapy Industry

949

Hepatitis C coinfection increases the risk of fulminant hepatic failure in patients with HIV in the HAART era

950

Hepatitis C detection

951

Hepatitis C detection

952

Hepatitis C genotype and associated risks factors of patients at University Kebangsaan Malaysia Medical Centre

953

Hepatitis C Genotypes Distribution in Intravenous Drug Users in Tehran

954

Hepatitis C Genotypes in Hemophilia Patients in Iran

955

Hepatitis C Genotypes in Hemophilia Patients in Iran

956

Hepatitis C impairs survival following liver transplantation irrespective of concomitant hepatocellular carcinoma

957

HEPATITIS C IN A COMMUNITY IN UPPER EGYPT: I. CROSS-SECTIONAL SURVEY

958

Hepatitis C in Australia: Impact of a Mass Media Campaign Original Research Article

959

Hepatitis C in haemophilia patients in the Netherlands

960

Hepatitis C in Hemodialysis Centers of Golestan Province, Northeast of Iran (2005)

961

Hepatitis C in hemodialysis patients needs more attention for control and review the risk factors

962

Hepatitis C in Iran. How Extensive of a Problem Is It?

963

Hepatitis C in Pakistan: A Review of Available Data

964

HEPATITIS C IN PERU: RISK FACTORS FOR INFECTION, POTENTIAL IATROGENIC TRANSMISSION, AND GENOTYPE DISTRIBUTION

965

Hepatitis C in State Correctional Facilities

966

Hepatitis C in the Eastern Mediterranean Region

967

Hepatitis C in the patient with human immunodeficiency virus infection

968

Hepatitis C Infection Among HIV-Positive Injection Drug Users and Non-Injection-Drug Users in Tajikistan

969

Hepatitis C infection and autoimmune hemolytic anemia in a patient with colon B-cell non-hodgkin lymphoma: a case report

970

Hepatitis C infection and polymyositis

971

Hepatitis C infection and risk of diabetes: A systematic review and meta-analysis

972

Hepatitis C infection from anti-D immunoglobulin

973

Hepatitis C Infection in Egyptian Psoriatic Patients: Prevalence and Correlation with Severity of Disease

974

Hepatitis C infection in Iran; A review article

975

Hepatitis C Infection in the General Population of Iran: A Systematic Review

976

Hepatitis C infection increases the risk of new-onset diabetes after transplantation in liver allograft recipients

977

Hepatitis C infection is characterized by a high incidence of liver cirrhosis, frequently requiring liver transplantation. After orthotopic liver transplantation, recurrence of hepatitis C virus infection is common, but often difficult to differentiate fr

978

Hepatitis C infection: a review on epidemiology and management of occupational exposure in health care workers for general physicians working in Iranian health network setting

979

Hepatitis C infection: a review on epidemiology and management of occupational exposure in health care workers for general physicians working in Iranian health network setting

980

Hepatitis C is associated with perturbation of intrahepatic myeloid and plasmacytoid dendritic cell function

981

Hepatitis C minimal residual viremia (MRV) detected by TMA at the end of Peg-IFN plus ribavirin therapy predicts post-treatment relapse

982

Hepatitis C NS3 helicase unwinds RNA in leaps and bounds

983

Hepatitis C NS3 protease inhibition by peptidyl-α-ketoamide inhibitors: kinetic mechanism and structure

984

Hepatitis C NS5B polymerase inhibitors: 4,4-Dialkyl-1-hydroxy-3-oxo-3,4-dihydronaphthalene-3-yl benzothiadiazine derivatives

985

Hepatitis C outbreak astounds Spain

986

Hepatitis C Prevalence and Risk Factors in the Northern Alberta Dialysis Population

987

Hepatitis C Prevalence and Risk Factors in the Northern Alberta Dialysis Population

988

Hepatitis C Rapid Point-of-Care Testing and Laboratory-based Non-invasive Assessment of Liver Fibrosis among Drug Abusers: An Experience from Iran

989

Hepatitis C seropositivity in patients with acute and chronic urticaria

990

Hepatitis C seroprevalence among intravenous drug users in Tehran

991

Hepatitis C seroprevalence among newly incarcerated inmates in the Texas correctional system

992

Hepatitis C therapy in treatment-naïve patients

993

Hepatitis C transmission associated with intravenous immunoglobulins

994

Hepatitis C transmission by cosmetic tattooing in women

995

Hepatitis C Treatment Among People Who Use Drugs in an Office-Based Opioid Treatment Program Versus a Syringe Exchange Program: A Real-World Prospective Clinical Trial

996

Hepatitis C treatment update

997

Hepatitis C Viral Heterogeneity Based on Core Gene and an Attempt to Design Small Interfering RNA Against Strains Resistant to Interferon in Rawalpindi, Pakistan

998

Hepatitis C viral IRES inhibition by phenazine and phenazine-like molecules

999

Hepatitis C viral kinetics in difficult to treat patients receiving high dose interferon and ribavirin

1000

Hepatitis C viral kinetics in plasma and peripheral blood mononuclear cells during pegylated interferon-α2a/ribavirin therapy

بازگشت